Ad is loading...
GH
Price
$29.11
Change
-$1.10 (-3.64%)
Updated
Nov 15 closing price
95 days until earnings call
VCYT
Price
$35.94
Change
-$1.10 (-2.97%)
Updated
Nov 15 closing price
106 days until earnings call
Ad is loading...

GH vs VCYT

Header iconGH vs VCYT Comparison
Open Charts GH vs VCYTBanner chart's image
Guardant Health
Price$29.11
Change-$1.10 (-3.64%)
Volume$3M
CapitalizationN/A
Veracyte
Price$35.94
Change-$1.10 (-2.97%)
Volume$1.63M
CapitalizationN/A
GH vs VCYT Comparison Chart
Loading...
GH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
GH vs. VCYT commentary
Nov 17, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GH is a Sell and VCYT is a Sell.

COMPARISON
Comparison
Nov 17, 2024
Stock price -- (GH: $29.11 vs. VCYT: $35.94)
Brand notoriety: GH: Notable vs. VCYT: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GH: 146% vs. VCYT: 200%
Market capitalization -- GH: $2.46B vs. VCYT: $1.66B
GH [@Medical Specialties] is valued at $2.46B. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GH’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • GH’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, VCYT is a better buy in the long-term than GH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GH’s TA Score shows that 5 TA indicator(s) are bullish while VCYT’s TA Score has 5 bullish TA indicator(s).

  • GH’s TA Score: 5 bullish, 6 bearish.
  • VCYT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VCYT is a better buy in the short-term than GH.

Price Growth

GH (@Medical Specialties) experienced а +1.75% price change this week, while VCYT (@Medical Specialties) price change was -1.48% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

GH is expected to report earnings on Feb 20, 2025.

VCYT is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GH($2.47B) has a higher market cap than VCYT($1.66B). VCYT YTD gains are higher at: 30.643 vs. GH (7.616). VCYT has higher annual earnings (EBITDA): -49.41M vs. GH (-433.3M). GH has more cash in the bank: 1.17B vs. VCYT (216M). VCYT has less debt than GH: VCYT (12.6M) vs GH (1.35B). GH has higher revenues than VCYT: GH (564M) vs VCYT (361M).
GHVCYTGH / VCYT
Capitalization2.47B1.66B148%
EBITDA-433.3M-49.41M877%
Gain YTD7.61630.64325%
P/E RatioN/AN/A-
Revenue564M361M156%
Total Cash1.17B216M541%
Total Debt1.35B12.6M10,746%
FUNDAMENTALS RATINGS
GH vs VCYT: Fundamental Ratings
GH
VCYT
OUTLOOK RATING
1..100
4034
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
40
Fair valued
PROFIT vs RISK RATING
1..100
10074
SMR RATING
1..100
9988
PRICE GROWTH RATING
1..100
3940
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VCYT's Valuation (40) in the Biotechnology industry is somewhat better than the same rating for GH (75) in the Medical Or Nursing Services industry. This means that VCYT’s stock grew somewhat faster than GH’s over the last 12 months.

VCYT's Profit vs Risk Rating (74) in the Biotechnology industry is in the same range as GH (100) in the Medical Or Nursing Services industry. This means that VCYT’s stock grew similarly to GH’s over the last 12 months.

VCYT's SMR Rating (88) in the Biotechnology industry is in the same range as GH (99) in the Medical Or Nursing Services industry. This means that VCYT’s stock grew similarly to GH’s over the last 12 months.

GH's Price Growth Rating (39) in the Medical Or Nursing Services industry is in the same range as VCYT (40) in the Biotechnology industry. This means that GH’s stock grew similarly to VCYT’s over the last 12 months.

GH's P/E Growth Rating (100) in the Medical Or Nursing Services industry is in the same range as VCYT (100) in the Biotechnology industry. This means that GH’s stock grew similarly to VCYT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GHVCYT
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
82%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 11 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Ad is loading...
GH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QFVRX11.32-0.03
-0.26%
Pear Tree Polaris Foreign Value R6
HNIDX12.61-0.06
-0.47%
Harbor Diversified Intl All Cp Retire
HRVIX38.96-0.39
-0.99%
Heartland Value Plus Investor
MGQSX21.28-0.26
-1.21%
Morgan Stanley Inst Global Stars R6
JDMRX133.03-1.66
-1.23%
Janus Henderson Enterprise R

GH and

Correlation & Price change

A.I.dvisor indicates that over the last year, GH has been loosely correlated with VCYT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GH jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GH
1D Price
Change %
GH100%
-3.64%
VCYT - GH
51%
Loosely correlated
-2.97%
NVCR - GH
44%
Loosely correlated
-2.78%
TWST - GH
41%
Loosely correlated
-5.31%
BLFS - GH
40%
Loosely correlated
-2.91%
HAE - GH
39%
Loosely correlated
-1.69%
More

VCYT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCYT has been closely correlated with NTLA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if VCYT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCYT
1D Price
Change %
VCYT100%
-2.97%
NTLA - VCYT
69%
Closely correlated
-7.61%
VCEL - VCYT
60%
Loosely correlated
-0.49%
AXON - VCYT
58%
Loosely correlated
-0.86%
DNA - VCYT
57%
Loosely correlated
-12.86%
ABCL - VCYT
55%
Loosely correlated
-3.99%
More